The source said that Sacklers would no longer own Purdue Pharma and would pay $ 3 billion out of their pocket, plus up to $ 1.5 billion more depending on the company's sales. Within this framework, Purdue's bankruptcy claim is seen as a strategy to maintain the company's value and pay off as many settlements as possible, the source added.
Purdue Pharma, which produces OxyContin, is at the center of the opioid crisis in America.
Yesterday, two state attorneys involved in the negotiations indicated that negotiations with the Sackler family had failed, according to a letter provided to CNN by a person familiar with the negotiations.
According to a letter, the Sacklers rejected two proposals that included a $ 4.5 billion payment to creditors and states. No counter offers were given. Attorneys general in Tennessee and North Carolina also say they expect Purdue Pharma to file for bankruptcy protection "immediately."
A Purdue spokesman yesterday confirmed to CNN that the company wants to establish itself and "believes in an agreement that benefits the American public is now way better than years of wasteful litigation and appeals."